Bispecifics

Revolutionizing Autoimmune Disease Management with Soluble Bispecific Receptors

Gardiner Smith; Reiner Gentz, Ph.D.

Fab Biopharma

Female-Centric

Transforming Drug Development through a Female Perspective

Chia Chia Sun; William Freimuth, Ph.D., M.D.

Fab Biopharma

Developability

Mitigating Early Development Risks with Samsung Biologics DEVELOPICK™ Platform

Heonchang Lim

Samsung Biologics

Protein Degradation

PROTACS: Upgrading Small Molecule Inhibitors

Cynthia A. Challener, Ph.D.

Pharma's Almanac

Nice Insight API Report

Small Molecule API Discovery and Development Trends

April Stanley, MS MBA

Nice Insight

Genomics

Integrated Spatial Genomics: Real Potential to Provide Truly Novel Biological Insights

Cynthia A. Challener, Ph.D.

Pharma's Almanac

Molecular Machines

The Potential of Molecular Machines: Enhanced Drug Delivery and Beyond

Cynthia A. Challener, Ph.D.

Pharma's Almanac

3D Cell Culture

Unleashing the Power of 3D Cell Culture: Revolutionizing Research, Drug Discovery, and Biomedicine

Elizabeth Abraham, Ph.D.; Catherine Siler, Ph.D.

Corning Life Sciences

R&D

Integrating Digital Solutions to Streamline Biopharma Operations

Christian Olsen

Dotmatics

Oncology

Addressing Cancer Therapy Resistance by Targeting Translational Regulation

Steve Worland, Ph.D.

eFFECTOR

Generative AI

Simplifying Target Discovery with an Artificial Intelligence Engine and Natural Language Chat

Petrina Kamya, Ph.D.

Insilico Medicine

Targeted Protein Degradation

Targeted Protein Degradation Provides Promising Alternative to Address Unmet Medical Needs

Henrik Daub, Ph.D.

NEOsphere Biotechnologies GmbH

Tumor Microenvironment

Harnessing the Power of the Tumor Microenvironment with First-in-Class Therapies

Gil Efron

Purple Biotech

Digital Twin Technology

The Powerful Potential of Digital Twin Technology to Improve Drug Discovery, Development, Manufacturing, and More

David Alvaro, Ph.D.

Pharma's Almanac

Therapeutic Candidate

CytoDyn Takes Steps towards a Brighter Future

Cyrus Arman, Ph.D.

CytoDyn

Artificial Intelligence

Artificial Intelligence in Pharma, As Told by Artificial Intelligence

Pharma's Almanac

Artificial Intelligence in Antibody Design

Accelerated and Cost-Effective Antibody Design Using Artificial Intelligence

Sumana Sundaramurthy, Ph.D.

Sino Biological

Three Benefits of Using In Silico Technologies for Drug Discovery

Kimberly Brunner

Synthetic Biology

Synthetic Biology: A Potential Game-Changer for the Biopharma Industry

Cynthia A. Challener, Ph.D.; David Alvaro, Ph.D.

Pharma's Almanac